A Multicenter, Single Arm, Open-label Trial of Oxaliplatin Plus Capecitabine (XELOX) in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 23 Dec 2015
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 23 Dec 2015 Planned primary completion date changed to 1 May 2016.
- 18 Feb 2014 Status changed from not yet recruiting to recruiting, as per ClinicalTrials.gov record.
- 08 Jul 2013 New trial record